CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Medical Developments International - MVPau CFD

0.57
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.04
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022726 %
Charges from full value of position ($-4.32)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022726%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.000808 %
Charges from full value of position ($0.15)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.000808%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency AUD
Margin 5%
Stock exchange Australia
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.57
Open* 0.57
1-Year Change* -48.18%
Day's Range* 0.55 - 0.57
52 wk Range 1.37-5.36
Average Volume (10 days) 81.81K
Average Volume (3 months) 2.71M
Market Cap 150.17M
P/E Ratio -100.00K
Shares Outstanding 78.81M
Revenue 22.37M
EPS -0.17
Dividend (Yield %) N/A
Beta 1.91
Next Earnings Date Feb 22, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 0.55 -0.01 -1.79% 0.56 0.57 0.55
Mar 27, 2024 0.56 -0.01 -1.75% 0.57 0.58 0.56
Mar 26, 2024 0.58 0.00 0.00% 0.58 0.58 0.58
Mar 25, 2024 0.58 0.01 1.75% 0.57 0.59 0.56
Mar 24, 2024 0.56 0.00 0.00% 0.56 0.57 0.56
Mar 22, 2024 0.56 -0.01 -1.75% 0.57 0.57 0.55
Mar 21, 2024 0.57 -0.01 -1.72% 0.58 0.58 0.56
Mar 20, 2024 0.58 0.00 0.00% 0.58 0.58 0.55
Mar 19, 2024 0.58 -0.02 -3.33% 0.60 0.61 0.58
Mar 18, 2024 0.61 -0.03 -4.69% 0.64 0.64 0.60
Mar 17, 2024 0.65 0.02 3.17% 0.63 0.65 0.63
Mar 15, 2024 0.65 0.02 3.17% 0.63 0.65 0.63
Mar 14, 2024 0.63 -0.01 -1.56% 0.64 0.66 0.63
Mar 13, 2024 0.63 -0.04 -5.97% 0.67 0.67 0.63
Mar 12, 2024 0.66 0.01 1.54% 0.65 0.67 0.64
Mar 11, 2024 0.66 -0.02 -2.94% 0.68 0.68 0.65
Mar 10, 2024 0.69 0.00 0.00% 0.69 0.69 0.69
Mar 8, 2024 0.69 -0.04 -5.48% 0.73 0.73 0.68
Mar 7, 2024 0.73 -0.03 -3.95% 0.76 0.76 0.73
Mar 6, 2024 0.76 0.01 1.33% 0.75 0.77 0.74

Medical Developments International Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 32.337 21.943 25.343 22.871 21.324
Revenue 32.337 21.943 25.343 22.871 21.324
Cost of Revenue, Total 10.125 6.735 6.173 7.543 6.692
Gross Profit 22.212 15.208 19.17 15.328 14.632
Total Operating Expense 59.319 38.219 40.322 22.55 19.773
Selling/General/Admin. Expenses, Total 39.372 27.958 21.909 12.057 10.409
Interest Expense (Income) - Net Operating 0.121 0.114 0.071
Other Operating Expenses, Total 0.738 1.582 1.338
Operating Income -26.982 -16.276 -14.979 0.321 1.551
Net Income Before Taxes -7.492 -15.908 -14.978 0.321 1.551
Net Income After Taxes -5.609 -12.407 -12.565 0.379 1.038
Net Income Before Extra. Items -5.609 -12.407 -12.565 0.379 1.038
Net Income -5.609 -12.407 -12.565 0.379 1.038
Income Available to Common Excl. Extra. Items -5.609 -12.407 -12.565 0.379 1.038
Income Available to Common Incl. Extra. Items -5.609 -12.407 -12.565 0.379 1.038
Diluted Net Income -5.609 -12.407 -12.565 0.379 1.038
Diluted Weighted Average Shares 84.2744 71.2778 69.5716 66.9736 66.0096
Diluted EPS Excluding Extraordinary Items -0.06656 -0.17407 -0.18061 0.00566 0.01572
Dividends per Share - Common Stock Primary Issue 0 0 0.01968 0.03936
Diluted Normalized EPS -0.14591 -0.1633 -0.00822 0.00566 0.01572
Depreciation / Amortization 3.113 2.945 2.425 1.254 1.263
Unusual Expense (Income) 6.709 0.581 8.956
Other, Net 18.928 0 0.001
Interest Income (Expense), Net Non-Operating 0.562 0.368
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 18.412 13.925 12.346 9.597 12.742
Revenue 18.412 13.925 12.346 9.597 12.742
Cost of Revenue, Total 6.089 4.036 2.743 3.992 3.377
Gross Profit 12.323 9.889 9.603 5.605 9.365
Total Operating Expense 29.839 29.48 18.804 19.047 26.371
Selling/General/Admin. Expenses, Total 22.918 16.454 22.865 13.109 17.401
Interest Expense (Income) - Net Operating -0.394 0.026 0.056
Other Operating Expenses, Total -9.355 1.339 -3.419
Operating Income -11.427 -15.555 -6.458 -9.45 -13.629
Net Income Before Taxes -11.014 3.522 -6.458 -9.45 -13.628
Net Income After Taxes -8.267 2.658 -5.029 -7.378 -11.428
Net Income Before Extra. Items -8.267 2.658 -5.029 -7.378 -11.428
Net Income -8.267 2.658 -5.029 -7.378 -11.428
Income Available to Common Excl. Extra. Items -8.267 2.658 -5.029 -7.378 -11.428
Income Available to Common Incl. Extra. Items -8.267 2.658 -5.029 -7.378 -11.428
Diluted Net Income -8.267 2.658 -5.029 -7.378 -11.428
Diluted Weighted Average Shares 86.2721 88.6348 70.1188 72.4368 72.3587
Diluted EPS Excluding Extraordinary Items -0.09582 0.02999 -0.07172 -0.10185 -0.15794
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.10108 0.09305 -0.07172 -0.09664 0.00781
Unusual Expense (Income) -0.697 7.406 0 0.581 8.956
Other, Net 0 18.928 0 0.001
Depreciation / Amortization 1.529 1.584 2.945
Interest Income (Expense), Net Non-Operating 0.413 0.149
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 42.762 34.369 47.387 25.957 35.354
Cash and Short Term Investments 24.661 20.398 36.277 15.544 25.62
Cash & Equivalents 24.661 20.398 36.277 15.544 25.62
Total Receivables, Net 8.932 6.246 4.985 4.115 6.384
Accounts Receivable - Trade, Net 8.769 5.895 2.545 3.923 6.273
Total Inventory 8.378 7.105 5.728 5.882 3.049
Prepaid Expenses 0.791 0.62 0.397 0.416 0.301
Total Assets 101.313 92.22 100.175 84.759 84.801
Property/Plant/Equipment, Total - Net 12.122 11.552 11.704 11.781 8.558
Property/Plant/Equipment, Total - Gross 22.254 20.133 18.934 17.687 13.121
Accumulated Depreciation, Total -10.132 -8.581 -7.23 -5.906 -4.563
Goodwill, Net 3.808 3.808 4.389 9.095 9.095
Intangibles, Net 34.509 36.879 34.458 35.82 29.665
Other Long Term Assets, Total 8.112 5.612 2.237 2.106 2.129
Total Current Liabilities 15.548 10.481 6.96 8.213 8.395
Accounts Payable 13.324 5.174 3.302 3.841 2.03
Accrued Expenses 0.727 0.683 3.253 1.561 1.733
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.352 0.348 0.337 0.417 0.091
Other Current Liabilities, Total 1.145 4.276 0.068 2.394 4.541
Total Liabilities 19.998 34.922 31.873 41.421 40.213
Total Long Term Debt 2.208 2.465 2.712 2.939 0.091
Long Term Debt 0 0 0.091
Other Liabilities, Total 2.242 21.976 22.201 30.269 31.727
Total Equity 81.315 57.298 68.302 43.338 44.588
Common Stock 105.729 76.992 76.895 40.954 40.41
Retained Earnings (Accumulated Deficit) -28.288 -22.679 -10.532 1.627 3.47
ESOP Debt Guarantee 3.94 2.976 1.969 0.802 0.711
Other Equity, Total -0.066 0.009 -0.03 -0.045 -0.003
Total Liabilities & Shareholders’ Equity 101.313 92.22 100.175 84.759 84.801
Total Common Shares Outstanding 86.3052 72.4571 72.4161 66.6838 66.5755
Capital Lease Obligations 2.208 2.465 2.712 2.939 0
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 42.762 54.638 34.369 40.481 47.387
Cash and Short Term Investments 24.661 37.121 20.398 28.275 36.277
Cash & Equivalents 24.661 37.121 20.398 28.275 36.277
Total Receivables, Net 8.932 5.99 6.246 5.342 4.985
Accounts Receivable - Trade, Net 8.932 5.99 6.084 3.005 2.648
Total Inventory 8.378 10.582 7.105 6.298 5.728
Other Current Assets, Total 0.566 0.397
Total Assets 101.313 109.011 92.22 96.024 100.175
Property/Plant/Equipment, Total - Net 12.122 11.542 11.552 11.599 11.704
Goodwill, Net 3.808 3.808 4.389
Intangibles, Net 38.317 37.961 36.879 35.833 34.458
Other Long Term Assets, Total 8.112 4.87 5.612 4.303 2.237
Total Current Liabilities 15.548 15.651 10.481 9.09 6.96
Payable/Accrued 6.002
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.352 0.341 0.348 0.342 0.337
Other Current Liabilities, Total 0.283 0.082 0.082 0.716 0.621
Total Liabilities 19.998 20.633 34.922 34.022 31.873
Total Long Term Debt 2.208 2.349 2.465 2.591 2.712
Capital Lease Obligations 2.208 2.349 2.465 2.591 2.712
Other Liabilities, Total 2.242 2.633 21.976 22.341 22.201
Total Equity 81.315 88.378 57.298 62.002 68.302
Common Stock 105.729 105.35 76.992 76.993 76.895
Retained Earnings (Accumulated Deficit) -24.414 -16.972 -19.694 -14.991 -8.593
Total Liabilities & Shareholders’ Equity 101.313 109.011 92.22 96.024 100.175
Total Common Shares Outstanding 86.3052 86.3052 72.4571 72.4317 72.4163
Long Term Debt 0
Accounts Payable 14.186 14.601 9.368 8.032
Prepaid Expenses 0.791 0.945 0.62
Accrued Expenses 0.727 0.627 0.683
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Cash From Operating Activities -10.777 -8.89 0.172 21.271 1.79
Cash Receipts 18.566 15.937 22.822 16.484 16.233
Cash Payments -31.653 -24.775 -20.896 -16.595 -15.482
Cash Taxes Paid 2.265 -0.021 -1.973 0.556 0.038
Cash Interest Paid -0.095 -0.075 -0.139 -0.071 -0.137
Changes in Working Capital 0.14 0.044 0.358 20.897 1.138
Cash From Investing Activities -5.159 -6.478 -8.472 -9.535 -10.676
Capital Expenditures -5.214 -6.56 -8.901 -9.865 -10.677
Other Investing Cash Flow Items, Total 0.055 0.082 0.429 0.33 0.001
Cash From Financing Activities 0.142 36.115 -1.966 13.043 7.973
Financing Cash Flow Items -0.003 -0.727 -0.013 -1.045 -0.01
Total Cash Dividends Paid 0 -2.065 -1.717 -1.239
Issuance (Retirement) of Stock, Net 0.36 37.074 0.4 24.875 0.4
Issuance (Retirement) of Debt, Net -0.215 -0.232 -0.288 -9.07 8.822
Foreign Exchange Effects -0.085 -0.014 0.19 0.047 0.016
Net Change in Cash -15.879 20.733 -10.076 24.826 -0.897
Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
Cash From Operating Activities -8.978 -10.777 -4.987 -8.89 -3.783
Cash Receipts 13.577 18.566 9.203 15.937 7.528
Cash Payments -22.694 -31.653 -14.286 -24.775 -11.284
Cash Taxes Paid 2.265 0 -0.021 -0.055
Cash Interest Paid -0.049 -0.095 -0.044 -0.075 -0.057
Changes in Working Capital 0.188 0.14 0.14 0.044 0.085
Cash From Investing Activities -2.626 -5.159 -3.009 -6.478 -2.493
Capital Expenditures -2.831 -5.214 -3.04 -6.56 -2.538
Other Investing Cash Flow Items, Total 0.205 0.055 0.031 0.082 0.045
Cash From Financing Activities 28.234 0.142 0.003 36.115 24.353
Financing Cash Flow Items -1.642 -0.003 -0.002 -0.727 -0.642
Total Cash Dividends Paid 0 0
Issuance (Retirement) of Stock, Net 30 0.36 0.1 37.074 25.1
Issuance (Retirement) of Debt, Net -0.124 -0.215 -0.095 -0.232 -0.105
Foreign Exchange Effects 0.093 -0.085 -0.009 -0.014 -0.153
Net Change in Cash 16.723 -15.879 -8.002 20.733 17.924

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Medical Developments International Company profile

Medical Developments International Limited
Industry: Pharmaceuticals (NEC)

4 Caribbean Drive
Scoresby
VICTORIA 3179
AU

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

Gold

2,210.01 Price
+0.690% 1D Chg, %
Long position overnight fee -0.0188%
Short position overnight fee 0.0106%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

70,848.60 Price
+2.790% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.63 Price
+1.230% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,573.88 Price
+1.710% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading